Marisol Martínez

No ORCID on file · 4 papers in corpus
rct 2019
Elagolix reduced dyspareunia and improved health-related quality of life in premenopausal women with endometriosis-associated pain
·doi:10.1177/2284026519872401

Objectives: The objective was to evaluate the effects of elagolix on dyspareunia in women with endometriosis-associated pain. Methods: Data were pooled from two similar, randomized, double-blind, placebo-controlled, 6-month phase 3 studies …

2018
Elagolix reduced dyspareunia and improved health-related quality of life in premenopausal women with endometriosis-associated pain
·doi:10.1016/j.fertnstert.2018.07.249
2018
Elagolix Reduced Dyspareunia and Improved Health-Related Quality of Life in Premenopausal Women with Endometriosis-Associated Pain
·doi:10.1016/j.jmig.2018.09.093
2018
Reductions in endometriosis-associated pain among elagolix-treated women are consistent across a range of baseline characteristics
·doi:10.1016/j.fertnstert.2018.07.254